MARKET

DHR

DHR

Danaher
NYSE

Real-time Quotes | Nasdaq Last Sale

218.35
+3.94
+1.84%
After Hours: 218.35 0 0.00% 16:42 03/05 EST
OPEN
216.00
PREV CLOSE
214.41
HIGH
219.32
LOW
212.55
VOLUME
2.43M
TURNOVER
--
52 WEEK HIGH
248.86
52 WEEK LOW
119.60
MARKET CAP
155.51B
P/E (TTM)
44.78
1D
5D
1M
3M
1Y
5Y
Top Insider Buys Highlight for the Week of March 5
Insiders load up on Exxon Mobil, Danaher, Lowe's Companies and Crown Castle International
GuruFocus.com · 18h ago
Danaher Corp. stock rises Friday, still underperforms market
Shares of Danaher Corp. advanced 1.84% to $218.35 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...
marketwatch.com · 1d ago
Danaher Corp. stock falls Thursday, underperforms market
Shares of Danaher Corp. slid 2.40% to $214.41 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...
marketwatch.com · 2d ago
Danaher To Present At Barclays Global Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 11:30 a.m. ET. The audio will be simultaneously...
PR Newswire · 2d ago
Danaher Corp. stock falls Wednesday, underperforms market
Shares of Danaher Corp. slipped 1.97% to $219.68 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...
marketwatch.com · 3d ago
Honeywell (HON) Displays Solid Prospects Amid Headwinds
Zacks.com · 3d ago
Microsoft, Oracle, Tesla, Virgin Galactic and More Wednesday Afternoon Analyst Calls
247WallSt.com · 3d ago
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021
Upgrades According to Wolfe Research, the prior rating for Fisker Inc (NYSE:FSR) was changed from Underperform to Peer Perform. In the fourth quarter, Fisker earned $0.05. At the moment, the stock has a 52-week-high of $31.96 and a 52-week-low of $14.32. F...
Benzinga · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DHR. Analyze the recent business situations of Danaher through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 22 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DHR stock price target is 268.88 with a high estimate of 284.00 and a low estimate of 245.00.
EPS
Institutional Holdings
Institutions: 2.21K
Institutional Holdings: 593.50M
% Owned: 83.33%
Shares Outstanding: 712.20M
TypeInstitutionsShares
Increased
592
25.05M
New
271
456.61K
Decreased
694
28.28M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/Director
Steven Rales
President/Chief Executive Officer/Director
Rainer Blair
Chief Financial Officer/Executive Vice President
Matthew McGrew
Executive Vice President
Daniel Comas
Executive Vice President
Jennifer Honeycutt
Executive Vice President
Joakim Weidemanis
Senior Vice President/Chief Accounting Officer
Robert Lutz
Senior Vice President/Chief Scientific Officer
Jose-Carlos Gutierrez-Ramos
Senior Vice President/Chief Compliance Officer/General Counsel
Brian Ellis
Senior Vice President/Director of Human Resources
Angela Lalor
Senior Vice President
William King
Senior Vice President
Daniel Raskas
Lead Director/Independent Director
Linda Hefner Filler
Director
Mitchell Rales
Independent Director
Teri List-Stoll
Independent Director
Walter Lohr
Independent Director
Walter Lohr,
Independent Director
Jessica Mega
Independent Director
Pardis Sabeti
Independent Director
John Schwieters
Independent Director
Alan Spoon
Independent Director
Raymond Stevens
Independent Director
Elias Zerhouni,
Independent Director
Elias Zerhouni
Declaration Date
Dividend Per Share
Ex-Div Date
02/23/2021
Dividend USD 0.21
03/25/2021
12/08/2020
Dividend USD 0.18
12/24/2020
09/15/2020
Dividend USD 0.18
09/25/2020
05/05/2020
Dividend USD 0.18
06/25/2020
02/20/2020
Dividend USD 0.18
03/26/2020
12/10/2019
Dividend USD 0.17
12/26/2019
09/10/2019
Dividend USD 0.17
09/26/2019
05/07/2019
Dividend USD 0.17
06/27/2019
03/08/2019
Dividend USD 0.17
03/28/2019
12/03/2018
Dividend USD 0.16
12/27/2018
09/11/2018
Dividend USD 0.16
09/27/2018
05/08/2018
Dividend USD 0.16
06/28/2018
02/20/2018
Dividend USD 0.16
03/28/2018
12/05/2017
Dividend USD 0.14
12/28/2017
09/12/2017
Dividend USD 0.14
09/28/2017
05/10/2017
Dividend USD 0.14
06/28/2017
02/22/2017
Dividend USD 0.14
03/29/2017
12/07/2016
Dividend USD 0.125
12/28/2016
09/14/2016
Dividend USD 0.125
09/28/2016
05/11/2016
Dividend USD 0.16
06/01/2016
03/02/2016
Dividend USD 0.16
03/22/2016
12/09/2015
Dividend USD 0.135
12/17/2015
09/21/2015
Dividend USD 0.135
09/30/2015
05/18/2015
Dividend USD 0.135
06/24/2015
02/25/2015
Dividend USD 0.135
03/25/2015
12/10/2014
Dividend USD 0.1
12/23/2014
09/09/2014
Dividend USD 0.1
09/24/2014
05/07/2014
Dividend USD 0.1
06/25/2014
02/19/2014
Dividend USD 0.1
03/26/2014
12/11/2013
Dividend USD 0.025
12/26/2013
09/12/2013
Dividend USD 0.025
09/25/2013
05/23/2013
Dividend USD 0.025
06/26/2013
  • All
  • Financials
  • Insiders
More
About DHR
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Webull offers kinds of Danaher Corporation stock information, including NYSE:DHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DHR stock methods without spending real money on the virtual paper trading platform.